interferonstimul
gene
isg
group
gene
product
coordin
combat
pathogen
invas
particular
viral
infect
transcript
isg
occur
rapidli
upon
pathogen
invas
classic
provok
via
activ
janu
kinasesign
transduc
activ
transcript
jakstat
pathway
mainli
interferon
ifn
howev
plethora
recent
studi
report
varieti
noncanon
mechan
regul
isg
transcript
new
studi
extrem
import
understand
quantit
tempor
differ
isg
transcript
specif
circumst
canon
noncanon
regulatori
mechan
essenti
defin
natur
host
defens
associ
detriment
proinflammatori
effect
comprehens
review
state
rapidli
evolv
field
clinic
implic
recent
acquir
knowledg
respect
ifnmedi
innat
immun
respons
form
forward
line
cellautonom
defens
pathogen
viru
invas
eg
presenc
singlestrand
rna
endosom
cytosol
doublestrand
rna
trigger
host
cell
recogn
infect
pattern
recognit
receptor
prr
turn
mediat
product
ifn
thusreleas
ifn
molecul
bind
cellsurfac
receptor
initi
signal
transduct
promin
involv
janu
kinasesign
transduc
activ
transcript
jakstat
pathway
activ
transcript
hundr
socal
isg
effector
cellautonom
antivir
defens
repres
wellstudi
isg
member
specif
broad
antivir
activ
includ
rigi
oasl
isg
act
differ
stage
viral
life
cycl
entri
replic
assembl
releas
lead
remark
antivir
state
provid
adequ
cellular
immun
posit
neg
doublestrand
rna
virus
dna
virus
even
intracellular
bacteria
parasit
although
jakstat
pathway
play
key
role
regul
isg
transcript
far
complex
cell
signal
network
canon
noncanon
mechan
involv
signal
strength
kinet
specif
regulatori
pathway
isg
transcript
modul
variou
level
distinct
mechan
oper
conjunct
understand
differ
mechan
isg
transcript
mode
action
relat
clinic
use
antivir
medic
provid
new
insight
virushost
interact
novel
avenu
antivir
drug
develop
therefor
aim
comprehens
review
classic
nonclass
mechan
regul
isg
transcript
emphasi
clinic
implic
transcript
regul
isg
defin
state
host
antipathogen
defens
light
recent
identifi
regulatori
element
mechan
ifnjakstat
pathway
new
insight
gain
classic
cascad
regul
isg
transcript
varieti
noncanon
mechan
recent
reveal
coordin
regul
isg
transcript
regard
advers
effect
ifn
clinic
isgbas
antivir
strategi
could
next
promis
frontier
drug
discoveri
wenshi
wang
lei
xu
junhong
su
maikel
p
peppelenbosch
qiuwei
pan
interferonstimul
gene
isg
group
gene
product
coordin
combat
pathogen
invas
particular
viral
infect
transcript
isg
occur
rapidli
upon
pathogen
invas
classic
provok
via
activ
janu
kinasesign
transduc
activ
transcript
jakstat
pathway
mainli
interferon
ifn
howev
plethora
recent
studi
report
varieti
noncanon
mechan
regul
isg
transcript
new
studi
extrem
import
understand
quantit
tempor
differ
isg
transcript
specif
circumst
canon
noncanon
regulatori
mechan
essenti
defin
natur
host
defens
associ
detriment
proinflammatori
effect
comprehens
review
state
rapidli
evolv
field
clinic
implic
recent
acquir
knowledg
respect
host
antivir
defens
ifnmedi
innat
immun
respons
form
forward
line
cellautonom
defens
pathogen
viru
invas
eg
presenc
singlestrand
rna
endosom
cytosol
doublestrand
rna
trigger
host
cell
recogn
infect
pattern
recognit
receptor
prr
turn
mediat
product
ifn
thusreleas
ifn
molecul
bind
cellsurfac
receptor
initi
signal
transduct
promin
involv
janu
kinasesign
transduc
activ
transcript
jakstat
pathway
activ
transcript
hundr
socal
isg
effector
cellautonom
antivir
defens
repres
wellstudi
isg
member
specif
broad
antivir
activ
includ
rigi
oasl
isg
act
differ
stage
viral
life
cycl
entri
replic
assembl
releas
lead
remark
antivir
state
provid
adequ
cellular
immun
posit
neg
doublestrand
rna
virus
dna
virus
even
intracellular
bacteria
parasit
although
jakstat
pathway
play
key
role
regul
isg
transcript
far
complex
cell
signal
network
canon
noncanon
mechan
involv
signal
strength
kinet
specif
regulatori
pathway
isg
transcript
modul
variou
level
distinct
mechan
oper
conjunct
understand
differ
mechan
isg
transcript
mode
action
relat
clinic
use
antivir
medic
provid
new
insight
virushost
interact
novel
avenu
antivir
drug
develop
therefor
aim
comprehens
review
classic
nonclass
mechan
regul
isg
transcript
emphasi
clinic
implic
transcript
regul
isg
defin
state
host
antipathogen
defens
light
recent
identifi
regulatori
element
mechan
ifnjakstat
pathway
new
insight
gain
classic
cascad
regul
isg
transcript
varieti
noncanon
mechan
recent
reveal
coordin
regul
isg
transcript
regard
advers
effect
ifn
clinic
isgbas
antivir
strategi
could
next
promis
frontier
drug
discoveri
upon
ifn
bind
cognat
cellsurfac
receptor
signal
transmit
membran
cell
via
jakstat
pathway
lead
rapid
transcript
activ
isg
decad
dedic
effort
elucid
classic
regulatori
network
outlin
figur
gene
encod
ifn
receptor
duplic
extens
throughout
vertebr
evolut
indic
substanti
evolutionari
pressur
system
combat
pathogen
distinct
ifn
genesprotein
identifi
base
type
receptor
signal
multitud
differ
ifn
mammalian
type
ifn
ifn
ifn
type
iii
ifn
type
ii
ifn
ifn
signal
correspond
receptor
complex
lead
phosphoryl
preassoci
janu
kinas
type
iii
ifn
phosphoryl
janu
kinas
tyrosin
kinas
turn
phosphoryl
receptor
specif
intracellular
tyrosin
residu
lead
recruit
phosphoryl
signal
transduc
activ
transcript
specif
tyrosin
residu
recruit
form
ifnstimul
gene
factor
type
ii
ifn
phosphoryl
tyrosin
kinas
phosphoryl
receptor
tyrosin
lead
homodimer
homodim
transloc
nucleu
phosphoryl
specif
serin
residu
therebi
achiev
full
activ
consequ
isg
transcript
activ
bind
homodim
ifnstimul
respons
element
isr
gactiv
sequenc
ga
promot
element
respect
convers
specif
phosphatas
nucleu
dephosphoryl
avoid
excess
detriment
respons
genom
classifi
three
major
type
ii
iii
human
type
ifn
includ
ifna
subdivid
differ
subtyp
ifnb
ifnd
ifn
ifnk
ifnt
type
ifn
bind
common
cellsurfac
receptor
type
ifn
heterodimer
receptor
complex
compris
two
subunit
ifna
receptor
ifna
receptor
unlik
type
ifn
one
type
ii
ifn
ifng
mark
structur
homolog
type
ifn
ifng
bind
differ
cellsurfac
receptor
compos
two
subunit
type
iii
ifn
famili
compris
four
member
frameshift
variant
signal
ifnl
receptor
ifnlr
compos
two
subunit
type
ii
ifn
signal
lead
phosphoryl
follow
homodimer
nuclear
transloc
dna
bind
gactiv
sequenc
ga
element
locat
within
promot
region
ifnginduc
gene
type
iii
ifn
signal
activ
similar
intracellular
jakstat
pathway
gener
transcript
complex
transcrib
isg
util
distinct
receptor
complex
signal
howev
ifnar
ubiquit
express
nucleat
cell
wherea
express
specif
tissuescel
epitheli
origin
suggest
select
type
iii
ifn
compar
type
ifn
optim
activ
signal
ifn
receptor
complex
depend
tyrosin
phosphoryl
serin
phosphoryl
acetyl
ifn
receptor
tabl
nevertheless
neg
regul
also
essenti
balanc
benefici
antivir
versu
detriment
proinflammatori
effect
primarili
achiev
phosphorylationinduc
ifn
receptor
ubiquitin
degrad
ii
block
interact
ifnar
downstream
signal
element
function
iii
receptormedi
ligand
internalizationdegrad
iv
modul
cellsurfac
ifn
receptor
level
jak
compris
four
member
three
function
ifn
signal
ubiquit
express
preassoci
correspond
ifn
receptor
upon
ifn
bind
receptor
becom
activ
closeproxim
transphosphoryl
tyr
tyr
tyr
subsequ
activ
jak
phosphoryl
cytoplasm
region
receptor
gener
dock
site
domaincontain
protein
particular
activ
jak
enzymat
activ
also
trigger
neg
feedback
antivir
immun
phosphatas
includ
cell
protein
tyrosin
phosphatas
tcptp
protein
tyrosin
phosphatas
ptp
import
neg
regul
protein
also
neg
regul
process
phosphorylationmedi
proteasom
degrad
jak
key
function
jak
cell
signal
made
ideal
target
control
rang
autoimmun
diseas
sever
jak
inhibitor
approv
fda
clinic
trial
treatment
rheumatoid
arthriti
psoriasi
inflammatori
bowel
diseas
ankylos
spondyl
seven
stat
member
mammal
import
stat
respect
ifn
signal
respons
ifn
phosphoryl
tyr
ser
ser
site
posit
relat
signal
transduct
acquir
transcript
activ
upon
tyrosin
phosphoryl
tyr
convers
serin
phosphoryl
ser
neg
regul
ifn
respons
although
jak
play
key
role
phosphoryl
activ
cellular
factor
also
requir
tyrosin
kinas
nonreceptor
retino
acidinduc
gene
rigi
potenti
dual
phosphoryl
tyr
ser
wherea
nuclear
cyclindepend
kinas
phosphoryl
ser
protein
kinas
c
famili
member
pkcd
pkce
mediat
phosphoryl
ser
effect
tyrosin
phosphoryl
via
upstream
phosphatidylinositol
akt
pathway
interestingli
stress
signal
also
induc
phosphoryl
ser
via
pathway
kinas
inhibitor
welltoler
safe
human
thu
tempt
specul
inhibitor
might
use
mitig
proinflammatori
effect
follow
ifng
therapi
evid
phosphatasedepend
dephosphoryl
constitut
import
negativeregulatori
event
central
titrat
ifn
respons
function
phosphatas
includ
nuclear
isoform
tcptp
phosphatas
dysregul
report
cancer
autoimmun
disord
thu
repres
potenti
therapeut
target
small
ubiquitinrel
modifi
also
report
conjug
ly
inhibit
signal
transduct
thu
plethora
molecular
mechan
balanc
ifn
respons
act
major
dna
bind
compon
complex
alon
bind
dna
recogn
specif
promot
element
denot
ifnstimul
respons
element
isr
transcript
activ
upon
dna
bind
provid
specif
proteindna
interact
site
activ
bind
isr
region
togeth
exert
strong
protranscript
activ
theoret
part
complex
involv
regul
isg
transcript
downstream
type
iii
ifn
signal
howev
ifnginduc
isg
activ
antivir
state
sever
impair
absenc
indic
may
also
involv
type
ii
ifn
signal
interestingli
ifng
pretreat
induc
high
level
serv
import
subunit
latent
precursor
way
ifna
ifng
synerg
induc
format
complex
lead
much
stronger
isg
transcript
case
type
iii
ifn
predomin
transcript
factor
bind
isr
within
promot
region
isg
wherea
type
ii
ifn
homodim
heterodim
stat
determin
bind
ga
element
howev
simplifi
model
regulatori
element
also
involv
figur
histon
octam
bind
dna
organ
chromatin
higherord
nucleosom
prohibit
transcript
factor
bind
gene
express
consequ
induct
isg
ifn
requir
chromatin
remodel
condens
chromatin
need
transform
relax
structur
human
nucleosom
remodel
complex
baf
pbaf
prime
isg
promot
util
atpderiv
energi
maintain
chromatin
constitut
open
conform
allow
fast
potent
induct
isg
ifn
exposur
histon
acetyl
deacetyl
also
essenti
chromatin
modul
reaction
typic
catalyz
enzym
histon
acetyltransferas
hat
histon
deacetylas
hdac
activ
hat
activ
transform
chromatin
relax
structur
hdac
activ
organ
chromatin
higherord
nucleosom
therefor
hat
famili
member
includ
essenti
transcript
activ
isg
hat
posit
regul
transcript
gener
howev
hdac
activ
also
essenti
transcript
induct
isg
hdac
activ
report
requir
recruit
rna
polymeras
ii
promot
isg
although
hdac
regul
transcript
activ
isg
remain
unclear
addit
pathway
coordin
modul
chromatin
structur
togeth
nuclear
corepressor
form
ternari
complex
facilit
close
chromatin
structur
therebi
limit
isg
transcript
basal
condit
howev
type
ifn
activ
kakt
pathway
turn
lead
degrad
isg
transcript
particular
coactiv
corepressor
mediat
transcript
isg
via
interact
homodim
coactiv
minichromosom
mainten
protein
complex
nmyc
interactor
nmi
facilit
transcript
activ
isg
convers
corepressor
protein
inhibitor
activ
stat
protein
piasg
suppress
format
transcript
complex
isg
promot
limit
transcript
recent
four
previous
unrecogn
regulatori
factor
lyn
isg
transcript
identifi
effort
led
comprehens
understand
isg
transcript
three
type
ifn
signal
jakstat
pathway
elicit
antivir
activ
nevertheless
type
ii
ifn
thought
homodim
wherea
type
iii
ifn
activ
form
togeth
howev
accumul
evid
highlight
far
complex
process
activ
function
beyond
classic
theori
heterogen
regulatori
mechan
isg
transcript
recent
highlight
substanti
fraction
cascad
littl
link
parallel
exist
noncanon
mechan
outsid
jakstat
axi
review
jakstat
axisdepend
independ
noncanon
mechan
isg
transcript
figur
date
three
differ
form
noncanon
complex
identifi
includ
ii
complex
unphosphoryl
ifng
treatment
report
lead
format
new
complex
ii
contain
phosphoryl
unphosphoryl
absenc
found
interact
form
complex
mediat
specif
isg
transcript
final
follow
continu
exposur
low
level
exogen
ifn
form
ifninduc
unphosphoryl
lead
increas
express
subset
isg
apart
also
involv
type
ifninduc
isg
transcript
interact
constitut
ifn
receptorassoci
upon
type
ifn
stimul
phosphoryl
tyrosin
serin
site
thu
act
dock
site
domain
crkl
crkl
form
complex
transloc
nucleu
bind
ga
element
activ
type
ifndepend
gene
transcript
irf
shown
function
transcript
factor
dna
sequenc
irf
site
recogn
overlap
isr
way
induc
subset
isg
also
enhanc
level
total
phosphoryl
amplifi
isg
transcript
via
jakstat
pathway
convers
bind
irf
site
repress
transcript
upon
viru
infect
activ
cooper
nfkb
form
transcript
activ
enhanceosom
complex
ifnb
promot
newli
synthes
ifn
bind
cognat
receptor
activ
isg
transcript
via
jakstat
pathway
importantli
also
report
directli
induc
subset
isg
ifnindepend
manner
isr
promot
well
document
combin
tnfa
type
ii
ifn
oper
cooper
induc
antivir
isg
express
tnfa
ifn
exert
synergist
antivir
effect
tnfa
report
inhibit
hepat
c
viru
hcv
infectioncaus
degrad
thu
maintain
ifn
signal
isg
express
tnfa
alon
alreadi
moder
induc
transcript
subset
isg
mainli
nfkb
protein
complex
key
downstream
element
tnfa
signal
may
explain
document
antivir
activ
tnfa
differ
virus
pathway
map
kinas
signal
regul
ifn
induc
isg
transcript
type
ifn
treatment
result
activ
downstream
effector
includ
map
kinas
kinas
map
kinas
kinas
cytosol
phospholipas
turn
event
provok
phosphoryl
activ
map
kinas
import
mediat
inflammatori
respons
map
kinas
activ
lead
downstream
activ
contribut
type
ifndepend
transcript
regul
isg
howev
map
kinas
signal
requir
ifndepend
phosphoryl
site
ser
tyr
impact
format
complex
histon
phosphoryl
chromatin
remodel
possibl
mechan
employ
cascad
mani
immunerelev
gene
product
subject
posttranscript
regul
signal
isg
investig
respect
respons
ifng
two
factor
bind
uniqu
ifngactiv
respons
element
known
gate
ccaatenhanc
bind
protein
cebpb
gate
bind
factor
upstream
kinas
necessari
activ
cebpb
respons
ifng
novel
ifngactiv
pathway
promot
isg
express
manner
nucleotid
synthesi
inhibitor
purin
pyrimidin
nucleotid
major
cellular
energi
carrier
subunit
nucleic
acid
nucleotid
synthes
de
novo
seri
enzymat
reaction
recycl
salvag
pathway
interestingli
purin
pyrimidin
synthesi
inhibitor
ribavirin
mycophenol
acid
brequinar
effici
induc
isg
express
exert
strong
broad
antivir
respons
howev
process
independ
classic
jakstat
cascad
suggest
noncanon
mechan
independ
ifn
ribavirin
inhibitor
impdh
enzym
shown
reset
subset
isg
promot
readi
activ
state
thu
potenti
isg
activ
howev
crosstalk
nucleotid
synthesi
innat
immun
respons
remain
elucid
ra
metabolit
vitamin
mediat
function
vitamin
growth
develop
ra
activ
transcript
via
heterodim
retino
acid
receptor
rar
retinoid
x
receptor
rxr
bind
region
promot
known
retino
acid
respons
element
rare
numer
studi
report
antivir
activ
ra
varieti
pathogen
interestingli
intracellular
ra
increas
isg
express
basal
level
augment
isg
induct
respons
ifn
consist
clinic
observ
ra
enhanc
respons
ifnbas
antivir
therapi
strikingli
bioinformat
studi
show
isg
regulatori
region
contain
rare
sequenc
indic
ra
induc
transcript
activ
isg
contain
rare
facilit
bind
addit
transcript
factor
promot
isg
consequ
ra
initi
work
synergist
ifn
induc
isg
express
ifn
use
variou
clinic
set
counteract
pathogenrel
diseas
robust
broad
antivir
activ
ifna
repres
standard
treatment
chronic
hepat
b
viru
hbv
hcv
infect
decad
applic
also
extend
viru
infect
offlabel
treatment
exampl
hepat
e
viru
sever
acut
respiratori
syndrom
ifnl
shown
play
crucial
role
cancer
autoimmun
diseas
viral
infect
antitumor
antiinfect
activ
ifng
comprehens
evalu
use
varieti
clinic
indic
approv
fda
treat
chronic
granulomat
diseas
osteopetrosi
experiment
use
treatment
idiopath
pulmonari
fibrosi
friedreich
ataxia
howev
ifng
success
treat
viral
infect
ifnl
shown
specif
antivir
activ
chronic
hbv
hcv
patient
although
efficaci
superior
compar
ifna
therapi
ifnl
limit
side
effect
restrict
tissuespecif
pattern
express
ifnl
also
shown
determin
intestin
epitheli
antivir
host
defens
rotaviru
infect
act
synergist
induct
isg
eventu
control
rotaviru
infect
anim
model
thu
ifnl
might
attract
option
treatment
mani
viral
infect
although
clinic
applic
ifn
particular
hcv
limit
recent
launch
directact
antivir
agent
may
extend
devast
viral
diseas
ebola
zika
dengu
viru
infect
mechanist
three
type
ifn
isg
ultim
antivir
effector
recent
studi
function
individu
isg
indic
differ
virus
target
uniqu
set
isg
isg
possess
broad
antivir
properti
wherea
other
specif
antivir
effect
thu
character
individu
isg
respect
antivir
spectrum
specif
provid
new
avenu
improv
current
antivir
therapi
interestingli
sever
isg
report
paradox
enhanc
replic
certain
virus
illustr
complex
network
mutual
interact
isg
virus
preclin
clinic
studi
express
pattern
specif
isg
identifi
biomark
predict
treatment
respons
diseas
progress
outcom
infecti
eg
hcv
hiv
infect
noninfecti
human
diseas
eg
syndrom
system
lupu
erythematosu
isg
eg
rigi
belong
class
prr
given
key
role
innat
immun
respons
grow
interest
target
prr
prevent
treatment
cancer
autoimmun
diseas
infect
specif
activ
undergo
preclin
clinic
evalu
safeti
efficaci
regard
advers
effect
ifn
clinic
isgbas
antivir
strategi
could
next
promis
frontier
drug
discoveri
decad
research
shape
pictur
complex
network
regul
isg
transcript
includ
canon
noncanon
mechan
within
outsid
ifnjakstat
axi
coordin
defin
cellular
defens
statu
pathogen
invas
expect
spectrum
new
element
involv
canon
noncanon
regul
isg
transcript
continu
grow
mechanismofact
clarifi
see
outstand
question
import
clinic
implic
knowledg
highli
relev
guid
develop
new
therapi
promot
erad
sever
pathogen
infect
avoid
autoimmun
diseas
toxic
effect
host
outstand
question
although
signal
receptor
mani
type
ifn
genom
cell
dynam
control
product
particular
member
type
ifn
upon
ifnl
bind
type
modif
eg
phosphoryl
acetyl
take
place
ifnlr
allow
trigger
isg
transcript
gener
hat
activ
transform
chromatin
relax
structur
hdac
activ
organ
chromatin
higherord
nucleosom
counterintuit
hdac
activ
report
requir
isg
transcript
underli
mechan
exactli
nucleotid
synthesi
pathway
mediat
isg
transcript
isgbas
antivir
strategi
circumv
issu
side
effect
caus
ifn
treatment
retain
therapeut
potenc
patient
